This study investigates borderline resectable pancreatic cancer. The purpose of this study is to explore the condition using an investigational medication combined with chemotherapy.
The study evaluates the safety and effectiveness of the investigational medication and chemotherapy combination. It looks into how well the treatment works and its safety profile.
- Who can participate: Adults aged 18 to 75 years with pancreatic cancer that can be surgically removed may join. Participants should not have had previous cancer treatments and need to meet health standards.
- Study details: Participants will receive treatment with an investigational medication and chemotherapy.